Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva stretches lead in generics

November 5, 2003
Sales and Marketing

Teva has agreed to acquire US generics company Sicor for $3.4 billion and increased its third quarter profits 63%, led …

News

Lilly resolves FDA manufacturing dispute

November 5, 2003
Manufacturing and Production

Two Eli Lilly manufacturing sites have passed FDA inspections resolving a long-running dispute and paving the way for the launch …

News

Private managers take over failing NHS hospital

November 5, 2003

News

Making the switch

November 5, 2003
Sales and Marketing P, POM, switch

Switching is not a given and a successful POM to P transition requires considerable research and planning to extend unique …

Feature

GSK looks to consolidate UK lead with Avandamet

November 4, 2003
Sales and Marketing

News

Paxil patent blow for GSK

November 4, 2003
Sales and Marketing

News

HRT – Too great a risk ?

November 4, 2003
Research and Development HRT, clinical trial

The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …

Feature

Crestor goes head-to-head with Lipitor

November 4, 2003
Sales and Marketing

News

Milburn defiant in face of foundation trust revolt

November 3, 2003

News

Parliamentary showdown for foundation trust plans

November 3, 2003

Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS …

News

Smallpox vaccine puts Acambis into profit

November 3, 2003
Research and Development

News

Generic threat to Lilly’s biggest seller

November 3, 2003
Sales and Marketing

A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …

News

Industry lukewarm on new labelling guidelines

October 31, 2003
Sales and Marketing

New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.The Government hopes the best …

News

GSK launches prostate drug

October 31, 2003
Sales and Marketing

GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.The …

News

Consultants threaten to quit

October 31, 2003

More than a quarter of hospital consultants are ready to resign or retire from the NHS if they dont receive …

News

GSK in running for Pfizer incontinence drug

October 31, 2003
Sales and Marketing

GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with …

News

Trusts warned over fixing waiting times

October 31, 2003

All NHS trusts will have to review how they report waiting times after a spot check found widespread distortion and …

News

Levitra brings three dimensions to ED market

October 31, 2003

Bayer and GlaxoSmithKline's new erectile dysfunction treatment Levitra has been launched in the UK, its first market after receiving European …

News

Staff shortages holding back NHS progress

October 31, 2003

A chronic shortage of staff in some parts of the NHS is holding back improvements to the service, according to …

News

BMS attempts to distance itself from fraud allegations

October 31, 2003

Bristol-Myers Squibb is attempting to draw a line under allegations of fraud and financial misconduct by downgrading earnings as far …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026